4 hours Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Given Average Rating of “Moderate Buy” by Brokerages MarketBeat
Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the twenty-four research firms that are presently covering the company, Marketbeat Ratings reports. Five equitie…